Joseph Caprini to Administration, Oral
This is a "connection" page, showing publications Joseph Caprini has written about Administration, Oral.
Connection Strength
0.387
-
Current state of knowledge on oral anticoagulant reversal using procoagulant factors. Ann Pharmacother. 2013 Jun; 47(6):841-55.
Score: 0.089
-
Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations. Ann Surg. 2009 Aug; 250(2):219-28.
Score: 0.068
-
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplasty. 2009 Jan; 24(1):1-9.
Score: 0.062
-
Deep vein thrombosis outcome and the level of oral anticoagulation therapy. J Vasc Surg. 1999 Nov; 30(5):805-11.
Score: 0.035
-
The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement. J Vasc Surg. 1999 Nov; 30(5):813-20.
Score: 0.035
-
Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient-specific thromboembolic risk. J Thromb Haemost. 2019 11; 17(11):1966-1972.
Score: 0.034
-
The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale. Thromb Haemost. 2017 12; 117(12):2415-2424.
Score: 0.030
-
Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res. 2010 Sep; 126(3):175-82.
Score: 0.018
-
Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis. Thromb Haemost. 2009 Jan; 101(1):77-85.
Score: 0.016